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Abstract A limitation for a universal use of T7 RNA
polymerase for in vitro tRNA transcription lies in the nature of
the often unfavorable 5P-terminal sequence of the gene to be
transcribed. To overcome this drawback, a hammerhead
ribozyme sequence was introduced between a strong T7 RNA
polymerase promoter and the tDNA sequence. Transcription of
this construct gives rise to a ‘transzyme’ molecule, the
autocatalytic activity of which liberates a 5P-OH tRNA
transcript starting with the proper nucleotide. The method was
optimized for transcription of yeast tRNATyr, starting with
5P-C1, and operates as well for yeast tRNAAsp with 5P-U1.
Although the tRNAs produced by the transzyme method are not
phosphorylated, they are fully active in aminoacylation with kcat
and Km parameters quasi identical to those of their phosphoryl-
ated counterparts.
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1. Introduction
Use of T7 RNA polymerase became popular for the prep-
aration of tRNA transcripts [1] despite some intrinsic limita-
tions linked to the nature of its promoter which encompasses
the six ¢rst nucleotides to be transcribed [2]. Although the
wild-type 5P-1GGGAGA6-3P internal promoter, present in
phage T7 genes, is the most e⁄cient for transcription, the
polymerase tolerates other internal nucleotide combinations.
E⁄ciency of transcription depends mainly on the nature of
the ¢rst nucleotide to be incorporated, namely a G-residue,
and subsequently that of the following ¢ve residues (but poor
transcription can also occur for molecules with seemingly fa-
vorable internal promoter sequences, as yeast tRNAVal start-
ing with G1 [3]). Since a majority of cytoplasmic tRNA se-
quences have a G1 residue [4], this method has been applied
successfully to prepare tRNA transcripts of many speci¢cities
and was, among others, the prerequisite for straightforward in
vitro studies on their identity [5]. However, several families of
natural tRNA lack a G at their 5P-end [3] and thus escaped
easy investigations. Likewise, a number of potential tRNA
variants in the amino acid acceptor stem one would like to
study for e¡ects on identity or other properties cannot be
prepared by classical in vitro transcription.
Based on the knowledge on small catalytic RNAs [6], we
have developed a method using a ribozyme to process tran-
scribed tRNA precursors. A hammerhead ribozyme gene se-
quence was introduced between a strong T7 RNA polymerase
G-rich promoter and the ¢rst nucleotide of the tDNA se-
quence. Because of the presence of the speci¢c and e⁄cient
natural G-rich promoter, it was expected that T7 RNA po-
lymerase would transcribe this gene e⁄ciently and produce
RNA molecules constituted by the hammerhead ribozyme fol-
lowed by the desired tRNA sequence terminating by -CCAOH.
It was anticipated that autocatalytic cleavage of the transcript
will take place in ‘cis’ just before nucleotide +1 of the tRNA,
generating full-length tRNAs with 5P-OH. As model tRNA to
establish the method we have chosen yeast tRNATyr starting
with 5P-CUCUCG, and thus very di⁄cult to produce by clas-
sical transcription with T7 RNA polymerase.
In this paper, we show (i) that large amounts of tRNATyr
transcripts can readily be obtained, (ii) that these transcripts
are fully active, despite the absence of a 5P-phosphate as in
canonical tRNATyr and (iii) that the method can be used as
well to prepare tRNAAsp transcripts starting with 5P-U1.
2. Materials and methods
2.1. Chemicals and enzymes
T7 RNA polymerase was puri¢ed as described in [7]. Oligonucleo-
tides were from NAPS GmbH (Goettingen, Germany), L-[14C]tyrosine
(448 mCi/mmol), [K-32P]ATP (3000 Ci/mmol) and [Q-32P]ATP (3000
Ci/mmol) from Amersham (Les Ulis, France). Restriction enzymes
(BstNI, HindIII, BamHI) and T4 polynucleotide kinase were from
New England Biolabs (Beverly, MA, USA). T4 DNA ligase was pur-
chased from Boehringer Mannheim (Meylan, France).
2.2. Puri¢cation of yeast TyrRS
The plasmid containing yeast TyrRS gene was overexpressed in
BL21(DE3)(pLysS). The enzyme was puri¢ed according to a method
described previously for puri¢cation of yeast ArgRS [8]. The activity
of the puri¢ed TyrRS was 883 U/mg/min.
2.3. Cloning and arti¢cial gene production
tRNATyr gene was cloned from eight overlapping oligonucleotides,
corresponding to T7 RNA polymerase promoter directly connected to
the sequence of yeast tRNATyr, as described in [9]. TranszymeTyr (for
terminology, see Section 3.1) was cloned from 10 overlapping oligo-
nucleotides, using the same protocol as for tRNATyr. Sequences of the
oligonucleotides used for tRNATyr cloning are given below. Numbers
1^4 correspond to the plus-strand and 5^8 to the minus-strand. For
transzymeTyr, oligonucleotides 1 and 2 were replaced by oligonucleo-
tides 9, 10 and 11, and 5 by 12 and 13 in order to construct the
precursor.
No. 1: 5P-AGCTTAATACGACTCACTATACTCTC-3P ; no. 2: 5P-
GGTAGCCAAGTTGGTTTAAGGCGC-3P ; no. 3: 5P-AAGACTG-
TAAATCTTGAGATCGGGCGT-3P ; no. 4: 5P-TCGACTCGCCCC-
CGGGAGACCAG-3P ; no. 5: 5P-GGCTACCGAGAGTATAGTGA-
GTCGTATTA-3P ; no. 6: 5P-TTACAGTCTTGCGCCTTAAACCA-
ACTT-3P ; no. 7: 5P-GAGTCGAACGCCCGATCTCAAGAT-3P ;
no. 8: 5P-GATCCTGGTCTCCCGGGGGC-3P ; no. 9: 5P-AGCTT-
AATACGACTCACTATAGGGAGAAGAG-3P ; no. 10: 5P-CTGAT-
GAGTCCGTGAGGACGAAACGGTACCCGGTACCGTC-3P ; no.
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11: 5P-CTCTCGGTAGCCAAGTTGGTTTAAGGCGC-3P ; no. 12:
5P-CGGACTCATCAGCTCTTCTCCCTATAGTGAGTCGTATTA-
3P ; no. 13: 5P-GGCTACCGAGAGACGGTACCGGGTACCGTT-
TCGTCCTCA-3P.
2.4. In vitro transcription
Run o¡ transcripts of tRNATyr were obtained by incubation for 3 h
at 37‡C of 50-Wl mixtures containing 40 mM Tris-HCl, pH 8.1, 22 or
30 mM MgCl2, 1 mM spermidine, 5 mM DTE, 0.01% Triton X-100,
4 mM of ATP, CTP, GTP and UTP, 16 mM CMP, 1 WCi [K-32P]ATP
(3000 Ci/mmol), 25 U T7 RNA polymerase, and 4 Wg of linearized
plasmid. Notice the presence of CMP in the incubation mixtures,
which was added to favor synthesis of molecules starting with a
5P-monophosphate instead of a 5P-triphosphate. Run o¡ transcripts
of transzymeTyr were obtained under similar conditions without CMP.
After transzyme transcription, reaction mixtures were either incu-
bated 1 h at 60‡C or diluted 5 times and then incubated 1 h at 60‡C in
order to enhance autocatalytic cleavage. Reactions were stopped by
phenol/ether extraction followed by ethanol precipitation. Since T7
RNA polymerase makes some errors at the 3P-end of the transcripts
[10], full-length transcripts correctly ending with the 3P-CCAOH se-
quence have been puri¢ed by a 12% preparative denaturing gel
(40U30U0.2 cm3). The products of 1 ml of transzyme transcription
were loaded onto the gel in a 24-cm wide pocket and resolution to one
nucleotide is obtained after electrophoresis at 55 mA for W18 h.
Transcripts were eluted from gel slices using a Schleicher p Schuell
(Dassel, Germany) Biotrap. Concentrations of transcripts were calcu-
lated from absorbance measurements at 260 nm, assuming that 1 ab-
sorbance unit (1 cm pathway) corresponds to 40 Wg/ml.
2.5. Aminoacylation assays
Activity of the synthesized transcripts was tested by their amino-
acylation capacity. Transcripts were renatured by heating 2 min at
60‡C and slowly cooling to room temperature. Aminoacylation reac-
tions were performed in 150 mM HEPES-NaOH, pH 7.5, 15 mM
MgCl2, 10 mM ATP, 0.5 mg/ml BSA, 20 WM DTE, 11 WM 14C-
labeled tyrosine (560 cpm/pmol), and appropriate amounts of tRNA
transcripts and yeast TyrRS. After incubation at 30‡C, aliquots were
removed, spotted on Whatman 3 MM paper, and trichloroacetic acid
precipitated. Incorporation of radioactive tyrosine was measured by
liquid scintillation spectroscopy. Kinetic constants (Km, kcat) were
derived from Lineweaver-Burk plots. Since the concentration of ami-
no acid was subsaturating, only apparent kinetic parameters are giv-
en. They represent an average of at least two independent experi-
ments. Errors on kinetic parameters are about 20%.
2.6. Analysis of the 5P-terminus of transcripts
The lack of a 5P-phosphate in the ribozyme processed tRNA tran-
scripts was checked by phosphorylation of the 5P-extremity of these
molecules in the presence of [Q-32P]ATP, using phage T4 polynucleo-
tide kinase as described by [11]. Transcripts classically obtained, and
possessing a 5P-phosphate, were submitted to this treatment as neg-
ative control. Aliquots of the reaction mixtures were submitted to
electrophoresis onto 12% denaturing polyacrylamide gel.
3. Results and discussion
3.1. Methodology
Although tRNAs are widely studied for their structure and
function, some of them escape profound investigations be-
cause of di⁄culties to obtain their corresponding in vitro tran-
script. These di⁄culties are due to the sequence of the pro-
moter recognized by T7 RNA polymerase which encompasses
the 6 ¢rst nucleotides to be transcribed. Among the 46 possi-
ble internal promoter sequences, those rich in G residues at
their most terminal 5P-positions are good substrates of the
polymerase and conversely, those starting with non-G resi-
dues, and sometimes even if starting with G, are poor sub-
strates.
In this work, we propose a method to overcome this de-
pendence of transcription on the gene sequence. This method
is based on transcription of an arti¢cial gene constituted by an
autocatalytic RNA, a ribozyme, preceded by the strong wild-
type T7 promoter sequence and followed by the tRNA se-
quence (Fig. 1A). A BstN1 restriction site constitutes the
3P-end of the gene and should ensure production of transcripts
preferably terminating by a 3P-CCAOH-end. These RNA mol-
ecules are named ‘transzymeaa’ (with ‘trans’ for transfer,
‘-zyme’ for ribozyme, and the superscript for the amino acid
speci¢city). The choice of the ribozyme was dictated by size
and sequence requirements. The hammerhead ribozyme [12]
was the ideal candidate since its size is small and its sequence
can be easily adapted to the 5P-sequence of any tRNA. Only
four nucleotides, not involved in the catalytic activity, have to
be complementary to the 5P-end of the tRNA sequence, as
illustrated by the examples of tRNATyr and tRNAAsp (see
‘Hybridization Boxes’ or HB in Fig. 1B). This hybridization
box may be of variable size depending on the thermodynamic
stability of the base-pairs formed between the promoter and
the 5P-end of the tRNA. The 5P domains of transzymes are
further expected to fold in the hammerhead 3D structure, so
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Table 1
Comparative in vitro transcriptions of yeast tRNATyr and transzymeTyr genes
Procedures tRNATyr TranszymeTyr
1 2 3 4 5 6 7 8
Critical parameters for transcription and cleavage
For transcription:
MgCl2 (mM) 22 30 22 30 22 30 22 30
For cleavage:
Temperature (‡C) ^ ^ 37 37 60 60 60 60
Dilution (x-fold) ^ ^ No No No No 5 5
tRNA production
Amount of transcript (pmol/50 Wl) 10 25 1353 2463 1200 2225 1523 2850
Transcription cyclesa (number) 2.3 5.7 274 520 254 471 340 638
Autocleavage of transcript (%) ^ ^ 11 42 44 42 86 88
Amount of tRNATyr (pmol/50 Wl) 10 25 143 1023 530 945 1313 2510
The numerical data correspond to the experiments displayed in Fig. 1C (the eight conditions assayed have the same numbering as the lanes of the
autoradiogram). The transcription conditions at 37‡C are described in Section 2.4 with changes for MgCl2 concentrations indicated. The changes in
temperature, Mg2 concentration, and dilution of the transcription mix to optimize cleavage conditions are indicated. The numerical values are for
50 Wl of transcription mix.
aNote that the theoretical number of cycles under conditions 3, 5 and 7 should be the same (experimental mean is 290 þ 45), as well as for
conditions 4, 6 and 8 (experimental mean is 540 þ 86).
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that the autocatalytic cleavage can take place in ‘cis’ just
before nucleotide +1 of the tRNA. This generates full-length
tRNAs with a 5P-OH instead of a 5P-phosphate in canonical
tRNAs (or of a mixture of pppN and pN, in transcripts pre-
pared by the conventional method).
3.2. tRNA preparation
The huge qualitative improvement of the transcription with
the transzymeTyr gene compared to the transcription with the
tRNATyr gene is clearly seen when one compares lanes 1 and
2 with lanes 3 and 4 in Fig. 1C. Optimal transcription con-
ditions turned out to be critically dependent on Mg2 concen-
tration (Fig. 1C and Table 1). Between 500 and 600 transcrip-
tion cycles could be obtained for the transzyme. This number
exceeds by 2 orders of magnitude that of the transcription of
the tRNATyr gene. Note that increasing the concentration of
MgCl2 from 22 to 30 mM gave a reproducible 2-fold increase
in yield.
A crucial step in the methodology is the autocatalytic cleav-
age of the transzyme. Under the basic conditions, this cleav-
age does not exceed W40% of the total transcription products
even at 30 mM MgCl2, known to be the optimal Mg2 con-
centration for ribozyme cleavage [12]. Note that cleavage is
more sensitive to Mg2 concentration than transcription. The
extent of cleavage could be improved after transcription, ei-
ther by rising the temperature from 37 to 60‡C (under sub-
optimal Mg2 concentration) or by diluting 5 times and heat-
ing the reaction mixture [13] (Table 1). Under this latter
condition, up to 90% of the transzyme molecules are cleaved
into tRNATyr and a RNA fragment corresponding to the
ribozyme as visualized on the autoradiogram (Fig. 1C). Sim-
ilarly high amounts of wild-type run o¡ transcript of yeast
tRNAAsp starting with the unfriendly 5P-UCCGUG sequence
could be obtained.
After cleavage, incubation mixtures were subjected to elec-
trophoresis on preparative denaturing polyacrylamide gels
(12%) to resolve length heterogeneities at the 3P-end of the
tRNAs. We considered the possibility to engineer a second
ribozyme at the 3P-end of the tRNA gene, and this was
worked out with yeast tRNAAsp. But in that case, generating
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Fig. 2. Single nucleotide resolution 12% polyacrylamide denaturing
gel. Lane 1: An aliquot of transcription mixture of transzymeTyr
and lane 2: puri¢ed tRNATyr were subjected to electrophoresis for
6 h at 70 mA. These conditions allow resolution between tRNATyr
transcripts and transcripts with a +1-extension.
Fig. 1. Arti¢cial transzymeaa gene, folding and production of its run o¡ transcript. A: Gene construction of the transzymeTyr. B: Structural or-
ganization of transzymeaa transcripts. The three domains of the transzyme are highlighted: (i) strong internal T7 promoter in bold, (ii) the
hammerhead ribozyme in italics and empty circles for its variable region, and (iii) a consensus sequence of tRNA with conserved and semi-con-
served residues indicated and variable residues given in black dots. Hybridization box (HB) is a ‘mixed’ domain constituted by the 4 nucleotides
(nts) immediately downstream the T7 promoter (a), the 4 ¢rst nts present at the 5P-end of the tRNA sequence (b), and the 4 nts opposite to
these latter in the 3P-part of the tRNA (c). Base-pairing of a and b occurs immediately after transcription of the concerned nucleotides. The
correctness of the folding is veri¢ed a posteriori by the e⁄cient cleavage at the position indicated by the arrow. After cleavage, base-pairing oc-
curs between b and c as demonstrated by the full activity of the liberated tRNA. C: Autoradiogram of the transcription products from
tRNATyr and transzymeTyr synthetic genes. A volume corresponding to 2 Wl transcription mix is loaded in each lane of the 12% polyacrylamide
denaturing gel. Lanes 1 and 2: Transcription of tRNATyr gene at 22 and 30 mM MgCl2, respectively. Lanes 3^8: Transcription of transzymeTyr
gene at 22 mM (lanes 3, 5, 7) or 30 mM MgCl2 (lanes 4, 6, 8), followed by 1 h at 60‡C (lanes 5 and 6), or by 5-fold dilution and 1 h at 60‡C
(lanes 7 and 8). To obtain visible bands of transcripts on lanes 1 and 2, the gel was exposed to autoradiography 4 times more than for lanes
3^8. Quanti¢cation of the bands was done using a Fujix Bio-Imaging Analyzer BAS 2000 system.
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aminoacylatable tRNA molecules involved a number of addi-
tional steps to remove the 2P^3P cyclic monophosphate gener-
ated by the ribozyme cleavage, so that the ¢nal yield of active
molecules was lower than that obtained after resolving the
length heterogeneity by electrophoresis. Therefore, we kept
the most simple option with a ribozyme only at the 5P-termi-
nus of the tRNA, especially since it is possible to resolve 3P-
length-heterogeneity to the resolution of one nucleotide. For
tRNATyr, the amount of molecules with a +1-extension was
less than 40% (Fig. 2).
3.3. Activity of 5P-OH tRNA transcripts
Aminoacylation capacity of E. coli dephosphorylated
tRNAs, speci¢c for serine, methionine, phenylalanine and his-
tidine, have already been tested. Except tRNAHis [14], all
tested tRNAs retain their capacity to be aminoacylated [15^
17].
Here, we address the question of the importance of the 5P-
phosphate group for tyrosylation and aspartylation. We ¢rst
proved the existence of a 5P-OH extremity for tRNATyr pro-
duced from the transzyme. Both tRNATyr species obtained by
classical transcription and by the transzyme method were sub-
jected to phosphorylation. Transcripts produced by transzyme
cleavage could be phosphorylated (up to 95% of the tran-
scripts were labeled with 32P), and conversely, no incorpora-
tion of radioactivity could be obtained on tRNATyr produced
by classical transcription (Fig. 3). It can be concluded that the
formed tRNA has a 5P-OH extremity which can be stoichio-
metrically phosphorylated. Therefore, the autocatalytic cleav-
age of the transzyme molecule generates as expected a 5P-OH
extremity.
Comparison of kinetic parameters (kcat and Km) for tyro-
sylation of both types of tRNA transcripts shows no di¡er-
ence (Fig. 4). This demonstrates that the 5P-phosphate extrem-
ity of tRNATyr is not required for tyrosylation activity.
Similar results were obtained for yeast tRNAAsp (data not
shown). Altogether, these results extend the earlier observa-
tions that had shown aminoacylation activity of dephospho-
rylated tRNA molecules. Interestingly, this property applies
for tRNAs speci¢c for class I and II synthetases whether these
molecules possess modi¢ed bases or are unmodi¢ed tran-
scripts.
3.4. Practical considerations and perspectives
The transzyme method typically yields W0.5 mg of full-
length tRNA transcript in a 1-ml transcription mixture. As
high amounts of T7 RNA polymerase are easily available
from an overproducing clone [2], all the required conditions
are present to apply this technique to any unfavorable se-
quence of tRNA or tRNA-like molecule for structural or
functional studies. The method will be essential for decipher-
ing the tyrosine identity in eukaryotes and especially for pre-
paring tRNAs from mitochondria and chloroplasts that often
do not start with G1. Equally important will be the use of the
transzyme method for systematic studies of functional proper-
ties of tRNA variants with mutations in the terminal part of
their amino acid accepting stems.
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